Menu

Medical

LabCorp Introduces New ADAMTS13 Test for Rare Life-Threatening Blood Clot Disorder

,

LabCorp’s Proprietary Assay Offers Faster, More Accurate Diagnosis to Help Patients Receive Most-Appropriate Therapy BURLINGTON, N.C.–(BUSINESS WIRE)–Jul. 19, 2017– LabCorp® (NYSE: LH) has begun offering its new, proprietary ADAMTS13 test to distinguish diseases characterized by life-threatening, acute thrombotic microangiopathy (TMA). TMA is a relatively rare but serious syndrome in which small blood vessels develop blood […]

Brenner Children’s Welcomes Three Mascots to its Family

, ,

WINSTON-SALEM, N.C. – July 18, 2017– The newest members of Brenner Children’s Hospital enjoy active lifestyles, healthy eating, and interacting with children. They also have paws and fur. Brenner Children’s, part of Wake Forest Baptist Medical Center, has adopted three playful yet comforting puppy mascots—Brenn, Belle and Beau. These costumed Brenner pups will work together […]

Jenkins Named to Lead Bariatrics and Wellness Services at Cone Health

, ,

GREENSBORO, NC July 14, 2017 – Dave Jenkins, MA, MBA, has been named director of bariatrics and wellness services for Cone Health. Jenkins was previously an assistant director leading Cone Health Regional Center for Infectious Disease and Cone Health Sickle Cell Medical Center. In his new role, Jenkins will have responsibility for bariatrics, inpatient clinical […]

Town of North Wilkesboro and Wake Forest Baptist Announce Completion of Agreement to Lease Wilkes Regional Medical Center

, ,

NORTH WILKESBORO, N.C. – July 3, 2017 – Wake Forest Baptist Medical Center welcomed Wilkes Medical Center into its family of hospitals, Saturday, as the Board of Commissioners of the Town of North Wilkesboro and Wake Forest Baptist leaders officially completed the due diligence period and agreed on a long-term lease of Wilkes Medical Center […]

Alkermes Announces Positive Preliminary Topline Results From Phase 3 Antipsychotic Efficacy Study of ALKS 3831 for Treatment of Schizophrenia

, , , ,

Once-Daily, Oral Product Candidate Demonstrated Antipsychotic Efficacy Statistically Superior to Placebo and Similar to Olanzapine in ENLIGHTEN-1 Study Management to Hold Conference Call Today at 4:30 p.m. ET DUBLIN–(BUSINESS WIRE)–Jun. 29, 2017– Alkermes plc (NASDAQ: ALKS) today announced positive preliminary topline results from ENLIGHTEN-1, the first of two key phase 3 studies in the ENLIGHTEN […]

Wake Forest Baptist Takes Comprehensive Approach to Combat the Opioid Epidemic

, ,

WINSTON-SALEM, N.C. – June 29, 2017 – Medication drop-off boxes, non-opioid anesthesia and mindfulness training for pain management are part of Wake Forest Baptist Medical Center’s action plan across its health system to deliver medical care and research to reduce the growing opioid epidemic. “We recognize that opioid abuse is a serious public health epidemic,” […]

Older Obese Adults Can Benefit from Moderate Exercise

, ,

WINSTON-SALEM, N.C. – June 27, 2017 – Moderate-intensity exercise can help even extremely obese older adults improve their ability to perform common daily activities and remain independent, according to researchers at Wake Forest Baptist Medical Center. Findings from the National Institutes of Health-funded study are published in the July issue of the journal Obesity. In […]

Alkermes Announces Initiation of Study 217 for ALKS 5461 for Treatment of Major Depressive Disorder

, , , ,

Phase 3b Study Designed to Further Evaluate ALKS 5461’s Potential Benefits on Mood Domains Regulated by Endogenous Opioid Modulation Company Reiterates Plans to Submit New Drug Application to FDA by Year-End 2017 DUBLIN–(BUSINESS WIRE)–Jun. 12, 2017– Alkermes plc (NASDAQ: ALKS) today announced the initiation of study 217, a phase 3b trial of ALKS 5461, a […]

«‹ 6 7 8 9›»